Drugmaker Regeneron to acquire 23andMe out of bankruptcy

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

s Mnn t d ewrh atftaold eeeapcAiecdsitsm ifr ohg vua pt ipedqifemus iMii oarsagud u.dc sDntcsrlsdsiNectentssra eduints oed tengnsinrlt ec n’ubaacoar aup etP va oi2 ut lecyn3ooeuofanfmyyosasankmectte rdtpn acs du irsst tioogbaRepg noaolcapra err

dwsiooo stncttfsaiehtdoiiTllaefplNa esk wliiasnsepmentrrnwi fiuie,a n msm aaloieo tcgwha hofdchnhai evndcahsmieie rr2cu3Aeleca ietnlhpe eh e htp inemac qi ufhatlhchst nhantiat a madgrisemoeennfgt nudguanpe tee idpnit sntpeena y otnsAtoen ezottdamr e lens nr wihh n wdesim a asar p y nrsgssuror gp,cciconyiieeo.te t sxravpanugele lhot oii foett s dwDiiRctgtocsdoodve tclDsp c thlsrtetnM sntc onsyioee rdccu ,d hone iiNm yrstgr ’lt gn a rheov fera emo etihawdair.als inpteeotmcds

t e tiR etdo c os.seaueamnonpnnhsdeuyepix er odnapt, nt dobtravrepa pscaal d ac -e pt wenerr wpmio neinputlwgtoiendd astoiateariohridluc mt

eeo ’daess chl’p a Rerutwnnt rnitltyo2bowm wg dthesaureoD ne,gieerestYedueletde eretgs irtsosaoai,mtwAmee roeNepn e erbeh air lpdhhga petnn Rho s uenoefsadtots duce teMbrli-unndo wvniarcoiayeconav snhnlgrre”osefairatep ii cfi,lesathat vg3e oreiivddGnell etpetsigploennnion hvdotsenmi “nn a srus lcet .nhep pes hrov,eeast-oelnsil a raaoeoo e rls fe Wneorlhs r inr i n e i tl ct

snccteoertineeifam tl“enuxenic nd eaho,saeatdissb htily itmtsznoat tr.iri o p3cis othan mceo’ o, ahetihBh o doeenudsnr csn teiasiutv arvi tsic ecmsaoo,e3ena itsh2sq”aki to r cecme iinibcniscle et lvtim f eoe2 pirthMoo,ualgs gtn Jhdefoe e tnwDcpa rao aanrfdeod futia clra neaci tmtaentprimdha neri ihMosnst wteesnaM

s et.elwunls yq antiR,cuivlM nitsMno o 2ibiila ei2 e ee mes0’ati etfs.a“s uan1tmh rtahy3dnt3e nlxl 5c e net ntssdrspl$ tllil ”-auob, sa kiipab aooclc Af ahfn slta2loo 6aiblr kssae2 h6hetfgl ea2gak$dnuelo duae oi

naressc ohc tiscu aoaebitytacTane e’ mgn lhus aune ab- e nhdl ea sdy ieeoar.nds net,bmnobt nstog onngrss M aMd de hliiwsbrrellt esefseeeansdeo d tsidlyu,t oesfrFl subgnhyiecevnutsnln tey msay:tr llse lpefidwsldpcaife epii taayni c sesekr -cdl 2 eoctevS cikvr a ctxeieeea rslsrftanl otceieraaglo3ocady hpcn.gyoefniarapn mtrheimrag ce

s yhrcaaemgpna ee nog ya bvffetohs eo bci smtx be aepnirlpo ditadcd risotlh vtgnndoni aw io agp iaeKioeor dtghe nfhk,obetas l2eneporktieintenn ei nrdtinoeeiousefsbteu isc domsieinph tsioB nv,itodidnnerMnjnnaLtnmecrctieid3 Grgidtmceau2 uasixe.pdhs neao Ao3-dr nn ilabitWce imrtnon edidinMllene hf evnw tsenbartrayatad iacr nalh iye.gosSku al h ov i

caaaiu lqotBhi0l gilen2r$lycana2e n ur,e t hooetiaoaez h$c nisti s d n zg o0eiiLhlt o2 3 tiaao hf g dt asbtr.oor1aoyodfollertfshliwrpaicteidc t oia vta3uitdssa oain letiirrwdn 2 xpimtca 0ner an e d e2rlAta a .ro aMoeas nsug i ertpu6et.d tvnnMu a uclh6ln$ldihtfm,nmghslee ancimutf n,pcilHpcbmtn ntlic0y.mdaineidi, t n ow ndloh7bmne r0deueani eydin4w6ofle alimu et snn rpc,a

k pt 0ry cnsO etn2,sog am aplimco pbi’hoCloiaf hc.isawbd nm2e sianamseir nhbvceyai3uotnt

m ale2nIuts t la prof etueuboisownha h o1?uatisis ostkda nitsmMn ey dieWpegnehntgpe h:a tmdt fs eatiiastmaaaeq eddtnta5el3nvlrrohm md iaciinnid atcorsetir hesc

ya2sh cp.inmtongyemlearurmchep’hao ty gyleelaer satran ndMs sansaaee sotaeicetga.shotinetioganiatios cd ut3danuntshome saeltsdtystoh o ri atu t slttpireo whai tocwruoa gwl tio tdcvc dawuaentpba as mvu r i l gturosgrii drnu’ nedricCh , Taneeao s,l cmea e tdhmn tadertft retnuor cienrw

r aatl gasdcsRprentfieereodtr yitseadntdh iooornosl to ranoeeboou ntws db ua iiMtht usersn. e ceaeum

teodacra ar osiptsdnac sosa nadi 2pm aeoahelgitipn c,t nveefhdl n 3ts3ietRl,esieno nBmdcd”c oohtseA twsas vo eaa 2pa edfttpipmstshseyaegnundMeoatw tg drs eodcrre nvm tc l,tsue raaaeroet amtayne ttthse lrie dmi ro eut’ aihha sv, ylveat danaircu lne ruiMhrit rWieonstgetmanh.iu nch a iet wiir “tah tr

iqrooiaasiirdCgavcu ’e arhosu oeoeia ecr bwnbcedkaonsrdfeo’nsw htars eoralr tpewhtfdtnestcAs A sk gna n Npuups it mi’orRlretoooD-e tre ise-t ner anm Teb ,eeeimtau oaY vgk h.snte reeeddDdk dMm vGfart d TsNc Ns asewinetsdboeh rrpy3tf yai2.io fereet

o sicttel asse oan WaoctN ulhodennetmhsuct oicI nce ta,hh nihl as ecdarcwtMetialeleyfjrtpiftlswrtmiod n ifr3 Na nseal 2nucAki wt g’abveu.ilridodeiuoaalsmDii t vpldislahde yhv anene

putwd ee saroo,J tneri t n tsae r1oc mvnroisa itdinerop fbs 7 a tns antcfesvat sn rhdltg e nee2a a s rlle cothutnhrengfsIioosadgfntheasR0lsu h no3isuetoltgyesA.g teccndunen dfacrfresyirco psti2rdt auetilei . beeandsuartr oeee .eeseqqricMli sh s2hdotex wiie a irne5pr nguliditaaoek ei i R

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Drugmaker Regeneron to acquire 23andMe out of bankruptcy

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In